FiEE, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K covers events occurring on October 27, 2025, the date of FiEE, Inc.'s 2025 Annual Meeting of Stockholders. The Company, incorporated in Delaware and headquartered in Hong Kong, reported on the ratification of its auditor, the election of directors, and the approval of equity-related proposals.
Key Financial Metrics and Capital Structure
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, or operating margins. However, it details specific capital structure changes:
- Convertible Note Conversion: A $300,000 unsecured promissory note issued to former executive David Lazar (bearing ~4.34% interest) automatically converted into 1,235,814 shares of Common Stock upon shareholder approval.
- Warrant Issuance: A warrant issued on July 2, 2025, to purchase 404,002 shares of Common Stock at an exercise price of $0.01 per share became exercisable following the Annual Meeting.
- Outstanding Shares (Record Date): As of September 11, 2025, there were 6,295,961 shares of Common Stock and 2,305,357 shares of Series A Convertible Preferred Stock outstanding.
Material Changes and Voting Results
Shareholders voted on five proposals at the Annual Meeting. All proposals were approved:
- Proposal 1 (Director Election): Cao Yu, Hu Bin, David Natan, and Chan Oi Fat were elected. Votes were overwhelmingly in favor (approx. 4.09 million "For" votes each).
- Proposal 2 (Auditor Ratification): UHY LLP was ratified as the independent registered public accounting firm for the fiscal year ending December 31, 2025 (4,699,219 "For" votes).
- Proposal 3 (Equity Issuance Approval): Shareholders approved the issuance of shares underlying the Seller Convertible Note and Seller Warrant (4,057,505 "For" votes).
- Proposal 4 (Equity Incentive Plan): The FiEE, Inc. 2025 Equity Incentive Plan was approved (4,079,906 "For" votes).
- Proposal 5 (Executive Compensation): The 2024 compensation of named executive officers was approved on an advisory basis (4,077,228 "For" votes).
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future operations, or specific risk factors beyond the standard disclosure of unregistered equity sales. The primary event reported is the execution of previously negotiated equity conversions and warrant exercises contingent on shareholder approval.
Key Facts for Investor Verification
- Verify the impact of the 1,235,814 new shares issued from the Convertible Note conversion on existing shareholder dilution.
- Confirm the status of the 404,002 warrants issued to David Lazar and the likelihood of exercise given the $0.01 strike price.
- Review the definitive Proxy Statement (Schedule 14A filed September 22, 2025) for details on the "Seller Convertible Note" and "Seller Warrant" referenced in Proposal 3.
- Note that the filing does not disclose current liquidity positions or debt obligations other than the specific note converted.